Skip to content

Controlled hypotension due to magnesium sulfate and remifentanil

A Comparison between the quality of controlled hypotension induced by Magnesium sulfate & Remifentanil in Lumbar PSF surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201111138091N1
Enrollment
40
Registered
2012-02-06
Start date
2010-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Instability of Lumbar Spine. Dislocation of other & unspecified parts of lumbar spine & pelvis

Interventions

Intervention 1: In group 1, Magnesium sulfate was administered with loading dose of 50mg/kg IV in 100cc Normal saline over 10 min, then with infusion pump the maintenance dose of magnesium sulfate (
Treatment - Drugs
In group 1, Magnesium sulfate was administered with loading dose of 50mg/kg IV in 100cc Normal saline over 10 min, then with infusion pump the maintenance dose of magnesium sulfate (15mg/kg/h) was a
In the second group remifentanil was administered until the end of operation with maintenance dose of 0.1- 0.2 microgram/kg /min IV with infusion pump.

Sponsors

Research vice-chancellor of Medicine faculty, Tehran university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria include: Individuals between 20-60 years old, candidate for PSF surgery, ASA I & II physical status, signing informed consent of study Exclusion Criteria includs: Allergic reaction to drugs, Liver, renal, cardiovascular failure, Ventricular and atrial arythmia and conduction heart disorders, Opioid consumption and drug abuse, Chronic therapy with opioids, NSAIDs and calcium channel blockers

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure. Timepoint: Continuous monitoring. Method of measurement: Invasive blood pressure monitorig with transducer and monitoring device.;Blood loss. Timepoint: During operation. Method of measurement: Calculating the amount of blood in the suction, surgical field and towels in cc.

Secondary

MeasureTime frame
Prevalence of transfusion in two groups. Timepoint: End of surgery. Method of measurement: Recording patients who need for transfusion and number of blood packs.;Arrhythmia. Timepoint: During operation. Method of measurement: Continuous ECG monitoring.;Bradycardia. Timepoint: During operation. Method of measurement: Continuous ECG monitoring.;Hypotension. Timepoint: During operation. Method of measurement: Continuous IBP monitoring.;Prevalence of need for TNG administration. Timepoint: Throughout the operation. Method of measurement: Recording patients who need TNG for controlling blood pressure.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKourosh Farazmehr

Tehran university of medical sciences

koroushfaraz@irimc.org+98 21 4408 6963

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026